Mallinckrodt and Terumo Blood and Cell Technologies Announce Positive Recommendations in Australia for Public Funding of UVADEX® (methoxsalen) for ECP Administr
– In a dual-review process, two independent advisory committees to the Australian Minister for Health recommended reimbursement based on a...
Source: fnarena.com